secwatch.observer — SEC 8-K summary
======================================

Issuer:     Benitec Biopharma Inc. (BNTC)
CIK:        0001808898
Form:       8-K
Filed at:   2024-10-08T23:59:59+00:00
Accession:  0001193125-24-234458
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Benitec Biopharma gets ~$21.1M from Suvretta warrant exercise; shares outstanding rise to 17.9M
--------------------------------------------------------------------------------

- Suvretta Capital waived 19.99% beneficial ownership limit on warrants; new cap set at 49.9%.
- Exercised 588,236 Series 2 warrants at $1.9299, 5,181,347 warrants at $3.86, and 1,368,180 pre-funded warrants at $0.0001.
- Issued total 7,137,763 shares to Suvretta funds for aggregate proceeds of ~$21.1 million.
- Outstanding common stock increased to 17,893,765 as of Oct 8, 2024, from ~10.6 million prior.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1808898/000119312524234458/0001193125-24-234458-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1808898/000119312524234458/d878957d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-234458

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer